Cisplatin as a Viable and Secure Alternative to Carmustine in BEAM-Based Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma.
B L Acosta-MaldonadoA Padilla-OrtegaO E Fernandez-VargasL Rivera-FongL M Valero-SaldañaE Calderon-FloresPublished in: Transplantation proceedings (2024)
Both BEAM and PEAM showed similar outcomes, demonstrating comparable efficacy in terms of ORR, TTR, and OS for both HL and NHL patients. However, PEAM-conditioning was associated with a shorter time to engraftment and fewer GI adverse events.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- bone marrow
- acute myeloid leukemia
- diffuse large b cell lymphoma
- stem cells
- type diabetes
- cell therapy
- adipose tissue
- mesenchymal stem cells
- metabolic syndrome
- patient reported
- weight loss
- electron microscopy
- glycemic control